GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹11,813 Cr | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr | ₹10,641 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹11,813 Cr |
| Mar2024 | ₹11,583 Cr |
| Mar2023 | ₹12,305 Cr |
| Mar2022 | ₹10,944 Cr |
| Mar2021 | ₹10,641 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,813 Cr | 1.98 | |
| Mar2024 | ₹11,583 Cr | -5.86 | |
| Mar2023 | ₹12,305 Cr | 12.44 | |
| Mar2022 | ₹10,944 Cr | 2.85 | |
| Mar2021 | ₹10,641 Cr | - | |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,634.7 Cr | -1.6% | 3.3% | 30.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.6% |
3.3% |
30.8% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses